Literature DB >> 4609586

Controlled cleavage of phage R17 RNA within the virion by treatment with ascorbate and copper (II).

K Wong, A R Morgan, W Paranchych.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4609586     DOI: 10.1139/o74-133

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


× No keyword cloud information.
  7 in total

1.  Site-specific cleavage of supercoiled DNA by ascorbate/Cu(II).

Authors:  Y Wang; B Van Ness
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

2.  Differences in growth response to hydrocortisone and ascorbic acid by human diploid fibroblasts.

Authors:  D W Rowe; B J Starman; W Y Fujimoto; R H Williams
Journal:  In Vitro       Date:  1977

Review 3.  The Use of Copper as an Antimicrobial Agent in Health Care, Including Obstetrics and Gynecology.

Authors:  Linda P Arendsen; Ranee Thakar; Abdul H Sultan
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

4.  Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells.

Authors:  S Harakeh; R J Jariwalla; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Copper complexes as prospective anticancer agents: in vitro and in vivo evaluation, selective targeting of cancer cells by DNA damage and S phase arrest.

Authors:  Dharmasivam Mahendiran; Sethu Amuthakala; Nattamai S P Bhuvanesh; Raju Senthil Kumar; Aziz Kalilur Rahiman
Journal:  RSC Adv       Date:  2018-05-09       Impact factor: 4.036

6.  The mechanism of DNA strand breakage by vitamin C and superoxide and the protective roles of catalase and superoxide dismutase.

Authors:  A R Morgan; R L Cone; T M Elgert
Journal:  Nucleic Acids Res       Date:  1976-05       Impact factor: 16.971

7.  Virus removal from drinking water using modified activated carbon fibers.

Authors:  Kamila Domagała; Jon Bell; Nur Sena Yüzbasi; Brian Sinnet; Dariusz Kata; Thomas Graule
Journal:  RSC Adv       Date:  2021-09-23       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.